Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BASE
4601
DELISTED
Couchbase
BASE
| $1.69M | ﹤0.01% |
+54,440
| New | +$2M |
|
4602
Vinci Compass Investments Ltd
VINP
$667M
| $1.69M | ﹤0.01% |
129,772
+19,200
| +17% | +$257K |
|
4603
Origin Bancorp
OBK
$1.66B
| $1.69M | ﹤0.01% |
39,859
-3,028
| -7% | -$124K |
|
4604
Dyne Therapeutics
DYN
$4.74B
| $1.69M | ﹤0.01% |
103,778
+99,122
| +2,129% | +$1.76M |
|
4605
iShares Convertible Bond ETF
ICVT
$7.33B
| $1.68M | ﹤0.01% |
16,877
-2,099
| -11% | -$211K |
|
4606
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$131M
| $1.68M | ﹤0.01% |
109,465
+1,422
| +1% | +$21.7K |
|
4607
TFS Financial
TFSL
$4.98B
| $1.68M | ﹤0.01% |
88,245
-40,902
| -32% | -$798K |
|
4608
Amneal Pharmaceuticals
AMRX
$5.77B
| $1.68M | ﹤0.01% |
314,383
+147,054
| +88% | +$740K |
|
4609
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$583M
| $1.68M | ﹤0.01% |
1,518
+863
| +132% | +$1.06M |
|
4610
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$141M
| $1.68M | ﹤0.01% |
31,545
-597
| -2% | -$32.2K |
|
|
LONA
4611
LeonaBio Inc
LONA
$71.5M
| $1.68M | ﹤0.01% |
17,877
-9,777
| -35% | -$995K |
|
4612
Arq
ARQ
$91.4M
| $1.68M | ﹤0.01% |
262,230
-105,623
| -29% | -$727K |
|
4613
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $1.67M | ﹤0.01% |
14,460
-8,615
| -37% | -$990K |
|
4614
iShares Government/Credit Bond ETF
GBF
$128M
| $1.67M | ﹤0.01% |
13,711
-1,456
| -10% | -$180K |
|
4615
NewtekOne
NEWT
$393M
| $1.67M | ﹤0.01% |
60,296
+16,824
| +39% | +$511K |
|
|
LADR
4616
Ladder Capital
LADR
$1.23B
| $1.67M | ﹤0.01% |
151,247
-96,598
| -39% | -$1.08M |
|
|
EXPR
4617
DELISTED
Express, Inc.
EXPR
| $1.67M | ﹤0.01% |
17,666
-37,434
| -68% | -$4.12M |
|
4618
BlackSky Technology
BKSY
$1.19B
| $1.67M | ﹤0.01% |
20,114
+18,023
| +862% | +$1.48M |
|
|
SLAI
4619
DELISTED
SOLAI Ltd ADS
SLAI
| $1.67M | ﹤0.01% |
2,911
-59
| -2% | -$31.4K |
|
|
NXQ
4620
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
| $1.66M | ﹤0.01% |
106,454
-8,504
| -7% | -$136K |
|
4621
Great Southern Bancorp
GSBC
$879M
| $1.66M | ﹤0.01% |
30,277
-6,432
| -18% | -$340K |
|
|
EEA
4622
European Equity Fund
EEA
$76.5M
| $1.65M | ﹤0.01% |
147,795
-5,945
| -4% | -$68.9K |
|
4623
VanEck Africa Index ETF
AFK
$104M
| $1.65M | ﹤0.01% |
79,295
+164
| +0.2% | +$3.52K |
|
4624
Lincoln Educational Services
LINC
$1.33B
| $1.65M | ﹤0.01% |
245,968
-2,118
| -0.9% | -$14.2K |
|
|
CTIC
4625
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.64M | ﹤0.01% |
556,477
-509,304
| -48% | -$1.39M |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,331 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.